Cardiometabolic Health and Inflammatory Resolution (REX)

Göteborg University

Status

Enrolling

Conditions

Volunteers

Study type

Observational

Funder types

Other

Identifiers

NCT04256330

2019-04179

Details and patient eligibility

About

The aim of this study is to determine how inflammatory resolution impacts cardiometabolic health and disease in subjects that are either lean (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2) or obese (>30.0 kg/m2).

Enrollment

200 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Informed signed consent has been obtained from the volunteer.
The volunteer has a BMI greater than 18.5 kg/m2

Exclusion criteria

The study staff contacting a potential participant perceives that the individual has difficulty understanding the information.
An MD determines that the individual is on too many medications to participate
The individual takes a medication that is approved by the MD, but he/she is not willing or not able to wait with any potential morning medication until after their fasted blood-draw.
The individual is younger than 18 years (relevant for the FAINT-1 and FAINT-2 cohorts)
The individual states that they have increased bleeding tendency or are using anti-coagulant (blood thinning) medication.
The individual has some form of chronic inflammation.
The individual regularly uses medication that affects inflammatory resolution (e.g., low-dose aspirin).
The individual uses immunosuppressive drugs (eg, methotrexate).
The individual regularly consumes fish oils (omega 3).
The individual has significant gastrointestinal problems.
The individual smokes or uses chewing tobacco.
The individual has been drinking alcohol two days before the study visit.
The individual has tattoos or body piercings on the forearms and / or the stomach that can affect the examination.
The individual does not follow instructions given in the research study.